AhR signaling in joint homeostasis and disease
Priyanka Brahmachary1, Emelia A Keim2, Seth T Walk2
1Department of Mechanical & Industrial Engineering, Montana State University, Bozeman, MT, USA.
Abstract:
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that integrates environmental, microbial, and metabolic signals to regulate gene expression across diverse tissues. Recent studies highlight AhR's role in skeletal homeostasis and joint biology, particularly through its interactions with microbiome-derived tryptophan metabolites and the Wnt/β-catenin signaling pathway. This review synthesizes current knowledge on AhR signaling mechanisms, including canonical and non-canonical pathways, and explores the impact of exogenous toxicants and microbiome-derived compounds and endogenous host metabolites that activate AhR. We discuss emerging evidence linking AhR activity to cartilage development, inflammation, and osteoarthritis progression, and highlight the utility of gnotobiotic mouse models in dissecting microbiome-AhR interactions. Finally, we examine the therapeutic potential of AhR modulation in joint disease, emphasizing its relevance as a pharmaceutical target for osteoarthritis and age-related musculoskeletal decline.
Related Concept Videos
The JAK-STAT Signaling Pathway
Cell Signaling in Plants
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Structural Joints: Synovial Joints
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Signal Transduction: Overview
Typically, signal transduction involves three...

